Portfolio company
Ablatus Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops a bimodal electric tissue ablation medical device to treat tumours and uterine fibroids for surgical patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
UTERINE FIBROID TREATMENT
This medical technology company develops a minimally invasive, uterus-sparing radiofrequency ablation system for women suffering from symptomatic uterine fibroids.
Interlace Medical
This company develops medical devices for gynaecological surgeons to remove uterine fibroids and polyps in office-based procedures.
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
LaNua Medical
This company develops embolisation devices that block blood flow in vessels to treat tumours and internal bleeding for radiologists and surgeons.
QV Bioelectronics
The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Affera
This medical technology company develops integrated cardiac mapping and ablation systems for electrophysiologists to treat patients suffering from heart rhythm disorders.
Allotrope Medical
This company develops a smooth muscle stimulation device to help surgeons identify ureters during pelvic operations.